Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2015 Nov 23;5:16917. doi: 10.1038/srep16917

Novel Mode of Defective Neural Tube Closure in the Non-Obese Diabetic (NOD) Mouse Strain

J Michael Salbaum 1,a, Claudia Kruger 2, Jacalyn MacGowan 1, Nils J Herion 2, David Burk 3, Claudia Kappen 2,b
PMCID: PMC4655353  PMID: 26593875

Abstract

Failure to close the neural tube results in birth defects, with severity ranging from spina bifida to lethal anencephaly. Few genetic risk factors for neural tube defects are known in humans, highlighting the critical role of environmental risk factors, such as maternal diabetes. Yet, it is not well understood how altered maternal metabolism interferes with embryonic development, and with neurulation in particular. We present evidence from two independent mouse models of diabetic pregnancy that identifies impaired migration of nascent mesodermal cells in the primitive streak as the morphogenetic basis underlying the pathogenesis of neural tube defects. We conclude that perturbed gastrulation not only explains the neurulation defects, but also provides a unifying etiology for the broad spectrum of congenital malformations in diabetic pregnancies.


Failure to close the neural tube results in birth defects1,2, with severity ranging from asymptomatic spina bifida occulta and surgically correctable cases of spina bifida to lethal conditions like exencephaly and anencephaly. Approximately 400 genes have been identified in the mouse where mutations either cause or contribute to neurulation defects3,4. In contrast, comparatively few genetic risk factors are known in humans5, highlighting the critical role of environmental risk factors, such as folic acid deficiency6 or maternal diabetes7,8,9,10. However, despite improved dietary folic acid supply and better glycemic control, the incidence of neural tube defects (NTDs) has been reduced only partially11,12. The extant risk for neural tube defects demands a better understanding how environmental factors interfere with embryonic development in general, and with neurulation in particular.

The Non-Obese Diabetic (NOD) strain of mice, which is prone to spontaneously develop autoimmune diabetes, is an established model for human type I diabetes13,14. Embryos of diabetic NOD pregnancies are afflicted with a very high rate of neural tube defects15 (NTDs), and heart defects16,17, another hallmark of diabetes teratogenicity. We here report that periconceptional supplementation with folinic acid in NOD diabetic dams reduced NTD incidence from 40.2% to 21% (p = 0.006, Supplemental Fig. 1). Thus, in parallel to human pregnancies, NTDs in this model are partially folate-responsive.

Unexpectedly, we found that in embryos from hyperglycemic NOD dams, the neural plate displayed protruding ectopic tissue in various locations along the anterior-posterior axis (Fig. 1a–f). Protrusions were strictly limited to diabetic pregnancies, and occurred in 25.3% of embryos at 8.5 days of gestation (E8.5). To test whether protrusions were unique to the NOD strain, we induced hyperglycemia in females of the FVB strain with Streptozotocin18, resulting in an NTD incidence of 21.6%19. At E8.5, 12.9% of hyperglycemia-exposed FVB embryos displayed protrusions (Fig. 1g,h). The overall appearance, location along the anterior-posterior axis, and internal organization (Fig. 1k) of protrusions were strikingly similar to the phenotype of exposed NOD embryos. Thus, these malformations are not a peculiarity of the genetic background of the NOD strain, but arise from the severe maternal hyperglycemia (Supplemental Table 1) common to both experimental models.

Figure 1. Neural plate protrusion phenotype in embryos from diabetic pregnancies.

Figure 1

(a) through (d), Embryos from diabetic pregnancies of the NOD strain with protrusions (triangles), generally in caudal locations. (e), NOD embryo with a protrusion at the hindbrain level, rostral to the neural tube closure front; lateral view; insert: view of the dorsal surface of the embryo. (f), NOD embryo with two protrusions: a small one at the mid/forebrain region, and a larger one in the trunk area. Insert: virtual sections through unaffected (top) and affected (bottom) neural plate areas. Compared to the unaffected region, the area affected by a protrusion displays an overall normal organization with the exception of a bulge at the midline. This bulge has an outer layer similar to and contiguous with the neuroepithelium, and a core where cell nuclei are sparse. (g,h), Embryos from diabetic pregnancies of the FVB strain display protrusions similar to those observed in the NOD strain. The embryo in panel g has two such malformations: a small one at the caudal end of the prospective hindbrain, and a larger one in the caudal trunk region. (i–k), Images derived from 3-dimensional reconstruction of confocal imaging data of whole embryos stained with DAPI. (i), Same embryo as in panel e, shown with a surface (purple) as calculated from volume data. The protrusion at the hindbrain level is clearly discernible. (j), Two aspects of a virtual parasagittal plane of section in ‘open-book’ presentation. The protrusion is contiguous with the neuroepithelium, with the core exhibiting a lower density of DAPI-stained cell nuclei, reminiscent of mesenchymal character. (k), ‘Open-book’ presentation of the FVB embryo shown in panel h. The morphological appearance of protrusions is similar in diabetes-exposed NOD and FVB embryos.

Imaging by 2-photon confocal microscopy, three-dimensional reconstruction of whole embryos from optical sections (Fig. 1i), and subsequent generation of single-plane views, allowed closer examination of the juncture between a protrusion and the embryo (Fig. 1j,k). We detected contiguity between the protrusion and the neural plate, with the outer layer resembling neuroepithelium. The core of a protrusion displayed lower cell density, reminiscent of mesenchymal character. This suggested that protrusions are not exclusively composed of neuroepithelial cells.

To determine the origin of protrusions, we performed gene expression profiling on microdissected protrusion tissue from the FVB model, using 3’-expression tag sequencing. For comparison, we laser-microdissected open neural tube immediately anterior of closure site 1 (Supplemental Fig. 2a–c). Analysis of Noto gene expression indicated that neural tube samples were free of potentially contaminating notochord (Supplemental Fig. 2d–h). We identified 799 genes with statistically significant differential expression in protrusions compared to open neural tube (Fig. 2a, Supplemental Figure 2j), and confirmed the sequencing-based observations by quantitative RT-PCR for selected genes (Fig. 2b). Hierarchical clustering demonstrated a clear distinction of expression profiles between protrusions and open neural tube (Supplemental Fig. 2i). Annotations for the 570 genes with predominant expression in protrusions were significantly enriched for the GO terms “mesoderm formation” and “mesoderm development”.

Figure 2. Molecular analysis of neural plate protrusions.

Figure 2

(a) Transcriptome profiling was performed by 3’-expression tag sequencing (SAGE) on an AB SOLiD 5500XL next generation sequencer. Comparisons between 3 individual protrusions (n = 3) and open neural tube neuroepithelium from 4 embryos (n = 4) were done using DESeq. Data are shown as a volcano plot, with statistical significance expressed as –log10(padj) plotted against the expression ratio (protrusion vs. neural tube). Gray color represents genes that did not reach statistical significance (Benjamini-Hochberg correction); red labels genes with expression prevalence in the protrusions; among these genes, blue color indicates genes with a known role in mesoderm development. Green indicates genes with prevalence in the open neural tube, with orange color indicating two genes of interest. Genes where expression was completely absent on one side of the paradigm were plotted at a log2 of either 10 or −10. (b) Validation of the expression difference of selected genes by quantitative real-time PCR. Eight genes with prevalence in protrusions (Acvr1b, Dll3, Mixl1, Nodal, Noto, T, Tbx6, and Wnt3a) were chosen for validation, and two genes (Fgfr2, Zic1) with expression predominant in the open neural tube. The same samples were analyzed from which the sequencing data were derived; thus, we measured gene expression levels in four technical replicates each of three protrusions, and in four technical replicates each of 4 neuroepithelium samples (from 4 individual embryos). Bars represent expression ratio between protrusions and neural tube expressed as log2. Statistical significance in a t-test is indicated by a star symbol. Expression ratios obtained from the sequencing experiment were confirmed for all candidate genes, except for Nodal, which exhibited the expected direction for the expression difference, but did not reach statistical significance.

For 85 of these genes, expression patterns at Theiler stages 11 to 13 (which correspond to gestational days E7.5 and E8.5) have been reported previously (MGI, http://www.informatics.jax.org/): 22 genes are known to be expressed in neuroectoderm and mesoderm, 33 are limited to mesoderm, 10 are expressed in the node, and 28 genes in the primitive streak (Supplementary Table 4). These results demonstrate that protrusions contain mesoderm, and they link protrusions to molecular networks that are active during gastrulation: Protrusions featured expression of genes known to be involved in early gastrulation, such as Nodal and Furin, which is required for Nodal activation20, and of components involved in maintenance of the primitive streak21, such as Fgf8, Wnt3a, and T/brachyury. We also detected targets of T, e.g. Cdx2, Axin2, and Lef1, together with 57 genes in the regulatory networks driven by T 22,23, as well as 153 downstream targets of Cdx222 (Supplemental Table 5); these included known axial, paraxial, and lateral mesoderm markers. Presence of these regulatory networks indicates that the mesenchymal cells in the protrusions have undergone the entire currently known mesoderm specification program.

Analyses of NOD embryos by in situ hybridization at E8.5 (Fig. 3) revealed parallels between protrusions arising from spontaneously initiating and chemically induced maternal hyperglycemia, respectively. Sox2, a marker for the epiblast/neuronal lineage24, was present throughout the outer layer of the protrusion, whereas T, a marker for primitive streak and nascent mesoderm25, was extended into the proximal core of the protrusion. Tbx6, a marker for committed mesoderm24,26, was found in the primitive streak and migrating cells of the mesodermal wings. Tbx6 expression in the core of a protrusion was reminiscent of proper mesoderm development27: expression was strongest where T expression had already been extinguished. Overall, these data indicate that migration of mesodermal cells is not completely blocked, but impaired locally around the protrusion.

Figure 3. Histological analyses of neural plate protrusions.

Figure 3

(a) Schematic of a mouse embryo at Theiler stage 11 (http://www.emouseatlas.org/). Black lines indicate the plane of sectioning for sections shown in panels (ce). Colors: purple – embryonic ectoderm and mesoderm; teal – amnion and allantois; blue – endoderm and yolk sac; yellow – deciduum. (b) Representation of a mouse embryo with a protrusion (red); black lines indicate series of sectioning planes for sections shown in panels (f-t) in rostral to caudal sequence, through the protrusion. (c) Section through the posterior region of an embryo from a normoglycemic NOD pregnancy at Theiler stage 11 after in situ hybridization with a probe for Sox2. The Sox2 signal is restricted to the epiblast/ectodermal layer. Stippled line represents the boundary of the embryo. (d) Adjacent section stained with a probe for T, revealing T expression in primitive streak and migrating nascent mesoderm. (e) Adjacent section developed with a probe for Tbx6, showing Tbx6 expression in the mesendodermal layer in the primitive streak, and the mesodermal wings. (f-t) Series of adjacent sections through an embryo from a diabetic NOD pregnancy at Theiler stage 11 featuring a protrusion. Panel (f) shows the initial rostral aspect of the protrusion, whereas panel (t) displays the most caudal section in the sequence. (f,i,l,o,r), Sections probed for Sox2 expression, which is detected in the outer layer of the protrusion. (g,j,m,p,s), Adjacent sections from the same embryo revealing expression of T. At the rostral aspect, T is detected at the base of the protrusion in a region reminiscent of the primitive streak. In the center of the protrusion (panel (m)), T is expressed in the outer layer as well as in the core. (h,k,n,q,t). Adjacent sections probed for expression of Tbx6. Tbx6 is prominently detected in the core of the protrusion, and is absent from the outer layer. Presence of Tbx6 in the mesodermal wings represents the normal expression for this gene in domains where the expression of T has already ceased.

The ectopic mesoderm in the protrusions could result from altered proliferation of newly generated mesodermal cells, or from disoriented migration of nascent mesoderm. Histological analyses support the second possibility: we did not find evidence for increased cell proliferation, as staining for the mitosis marker Phospho-Histone 3 did not reveal enrichment in protrusions compared to the rest of the embryo. Instead, we detected deposition of Laminin between mesodermal cells within and at the base of a protrusion (Fig. 4). This is paralleled by protrusion-prevalent expression of Laminin α5, Nidogen 2 (components of the basal lamina28,29), and Integrin α6, a receptor for Lama530, and is consistent with a previous report of elevated expression of extracellular matrix components in rat embryos exposed to hyperglycemia conditions31. These data implicate altered cell adhesion or impaired migration of mesodermal cells in the formation of protrusions.

Figure 4. Protrusions feature internal deposition of laminin.

Figure 4

Embryos at three different stages of development, featuring protrusions: E8.0, headfold stage (ad) E8.5 with open neural plate in the caudal region (eh) and E9.5 with a large protrusion interfering with neural tube closure (il). Sections were stained for DNA ((a,e,i); blue, Hoechst 33342), phosphorylated Histone 3 ((b,f,j); PH3, green), and Laminin ((c,g,k); red); merged color images are shown in (d,h,l) respectively. Abbreviations: ac, amniotic cavity; da, dorsal aorta; en, endoderm; ep, epiblast layer; hf, headfold; hg, hindgut; mw, mesodermal wing; np, neural plate; p, protrusion; so, somatopleura; spl, splanchnopleura. All protrusions, from the early stage to the mature stage, feature internal accumulations of laminin in the mesenchyme (yellow triangles). Furthermore, the outer cell layer is typically separated from the internal mesenchyme by a laminin-positive layer of extracellular matrix.

Evidence for impaired migration came from explant cultures (Fig. 5) under conditions that support migration and differentiation of mesoderm, confirmed by virtue of staining for Vimentin32 (Fig. 5b,c). In these cultures, outgrowth from posterior tissue explants of diabetes-exposed NOD embryos at E7.5, or at E8.5, was significantly reduced compared to migration from explants of embryos from normoglycemic NOD pregnancies (Fig. 6a). Furthermore, for diabetes-exposed embryos, we compared cultures of dissected protrusions to explants of the adjacent posterior tissue at E8.5. Cells from protrusions either failed to migrate away from the explant, or migrated significantly less compared to the outgrowth observed from the corresponding posterior tissue explant (compare within green frames: Fig. 5g,h,i to j,k,l, and Fig. 5m,n,o to p,q,r, respectively; and Fig. 6b). The reduced migration of cells away from protrusions cannot be attributed to developmental immaturity, as cells from earlier embryos exhibit comparable migratory capacity in these assays (Supplemental Fig. 3a); the extent of outgrowth was also uncorrelated to size of the starting explant (Supplemental Fig. 3b). We therefore conclude that the exposure to maternal diabetes is responsible for the impaired migratory capacity of mesoderm in protrusions. Finally, outgrowth of explants from diabetes-exposed NOD E8.5 embryos was reduced in comparison to explants of diabetes-exposed E8.5 embryos of the FVB strain (Fig. 6c), which could explain the higher incidence of protrusions in the NOD model compared to FVB.

Figure 5. Explant cultures of protrusions and posterior embryonic tissue.

Figure 5

Images of explant cultures. Fixed explants were stained with an antibody against Vimentin (green), Phalloidin (red) to detect Actin, and DRAQ5 (blue) to localize cell nuclei. Culture conditions supported migration and differentiation of mesoderm, including cardiac mesoderm, as evidenced by formation of rhythmically contractile centers in primitive streak explants of E7.5 embryos from normal NOD pregnancies (time-lapse video in Supplemental Information). Insets identify the area depicted in the close-up images. (a) The explant from a normal E7.5 NOD embryo had an area of rhythmically contracting myocytes (orange circle). (b) The same explant after staining, in darkfield contrast. (c) Close-up magnification of inset area. (df) Explant from a diabetes-exposed E8.5 NOD embryo. (gl,mr) Corresponding explants of posterior tissue and protrusion from the same embryo are grouped together by a green frame. Compared to posterior tissue from the same embryo, respectively, (gi,mo) protrusions exhibit very little outgrowth (jl,pr).

Figure 6. Exposure to maternal diabetes decreases cell migration in explant cultures.

Figure 6

Quantification of outgrowth from the explants as the net outward distance migrated by cells at the margin of each explant between hours 6 and 26 after initiation of culture. Asterisks mark statistical significance in a t-test (p < 0.05). (a) Posterior tissue explants from diabetes-exposed (exp., orange) NOD embryos display significantly reduced outgrowth compared to explants from normal (n, white) pregnancies at E7.5 (normal n = 10, exposed n = 7; p = 1.7 × 10−3; 96.7% power at alpha = 0.05) and E8.5 (normal n = 8, exposed n = 39; p = 6.7 × 10−4; 99.7% power at alpha = 0.05). (b) Explants of dissected protrusions (red) produced significantly less outgrowth than the corresponding posterior tissue (orange) from the same embryo (n = 12 pairs; p = 6.2 × 10−5; 99.9% power at alpha = 0.05) at E8.5. Note the difference in scale of the Y-axis. (c) Posterior tissue explants from diabetes-exposed E8.5 NOD embryos (orange; same data as in (a); n = 39) exhibit reduced outgrowth compared to explants from diabetes-exposed FVB embryos at E8.5 (purple; n = 6; p = 4.4 × 10−7; 100% power at alpha = 0.05).

These results also demonstrate that the culture conditions, including supportive extracellular matrix and growth factors present in fetal calf serum, are not sufficient to rescue the cell migration deficiencies during the 26 hours of culture of the explants. Culture at lower glucose concentrations had no effect on outcome (p = 0.23 for E7.5, p = 0.22 for E8.5). Thus, the explant cultures confirm our conclusion that the exposure in utero to maternal diabetes causes impaired cell migration and reduces egress from the primitive streak, which in the most severely affected individuals creates protrusions from the neural plate.

Protrusions have also been reported in 20 genetic models involving loss-of-function for the Cripto (Tdgf1), Eomes, Fgf8, Fgfr1, Lrp5/Lrp6, Map4k4 (Nik), Mesp1/Mesp2, Mixl1, Pten, Rac1, Ship2, T, Talin, and Tcf3 genes33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49, or ENU-induced mutations in the Axin2, Nckap1 (Nap1), Supt20 (p38IP) and Udgh genes50,51,52,53 (reviewed in54). Impaired mesoderm migration was implicated as mechanistic basis for such cell accumulations, and epiblast-specific ablation of Pten43 and Rac145 identified those genes as cell-autonomous regulators of mesoderm migration. Among 15 protrusion mutants where embryos survive to later stages of development, common outcomes are open neural tube or spina bifida (6 models), defective heart development (9 models), and caudal growth defects (9 models)54. In contrast to loss-of-function models in which expression is abolished, we detected expression of all these genes in diabetes-exposed embryos, with Axin2, Fgf8, Mesp1, Mesp2, Mixl1, and T particularly prevalent in protrusions (Fig. 2a and Supplemental Table 2), indicating that defective migration in our exposure models is not due to loss of mesodermal gene expression.

Intriguingly, protrusions formed at discrete anterior-posterior locations rather than along the entire primitive streak. Consistent with prior data55, we found that two thirds of NTDs in NOD embryos (~26% of all embryos) involve the trunk region of the embryo; this rate is comparable to a protrusion incidence of 25%, of which almost all appear in the territory covered by the primitive streak. In the FVB model, half the NTDs (~11% of all embryos) involve the trunk (unpublished observations), a rate that again parallels the protrusion incidence (12.9%). Thus, in both diabetes models, defective mesoderm migration can account for the vast majority of trunk and caudal neural tube defects in mouse diabetic pregnancies. Protrusions in more anterior locations were detected only occasionally (e.g. Fig. 1F and insert). Even within the primitive streak territory, protrusions were limited to unique locations, possibly indicative of a limited time window for perturbations that contribute to the formation of protrusions.

There are three possibilities how protrusions can cause neural tube defects: (i) by preventing formation of the medial hinge point that is required for initial bending of the neural plate56,57, (ii) by compromising elevation and bending of future neuroepithelium57 due to diminished cell migration into the underlying mesoderm, and (iii) by physically interfering with the closure of the neural tube at the dorsal midline. Given that these alternatives are not mutually exclusive, they require further investigation. Close examinations and histological analyses of embryos with protrusions (Fig. 7) revealed properly closed neural tubes rostral to the protrusion, with neurulation failure caudal to the protrusion, indicating that in these cases the protrusions physically interfered with closure of the neural tube.

Figure 7. Effect of protrusions on neural tube closure.

Figure 7

(a) Embryo at 9.5 days of gestation (and close-up) showing a protrusion emerging from underneath the dorsal roof of the neural tube, preventing closure towards the caudal end of the embryo. A schematic drawing and histological analysis are depicted in Supplemental Figure 4. (b) Embryo at E9.5 with a long protrusion emerging at approximately hind limb bud level, rendering the neural plate caudal to the protrusion open. (c) Embryo at E9.5 featuring a bifurcated protrusion (pink triangles point to the extensions of the protrusion) emanating from the neural tube at the level of the hind limb bud, rendering the neural tube open caudal to the point of emergence. Schematic drawing and histological analysis are provided in Supplemental Figure 4. (d) Embryo at E10.5 (lateral and dorsal view) with forebrain and midbrain closed, whereas neurulation failed caudal to the midbrain-hindbrain junction. A small protrusion (stippled black line) can be seen near the hindbrain–spinal cord junction. (e) Embryo at E10.5 with very small protrusion at the level of the forelimb bud. Neurulation was completed successfully along the neuraxis except for the small area of the protrusion. (f) Embryo at E10.5 with a larger protrusion slightly caudal to the forelimb bud (open triangle). The neural tube is closed rostral to the protrusion, whereas it remains open (white filled triangle) caudally from the protrusion all the way to the end of the neuraxis.

In this work, we have identified impaired mesoderm migration as the morphogenetic failure underlying the pathogenesis of NTDs. Since these NTDs are caused by an environmental risk factor, maternal metabolic disease, our findings imply that mesoderm migration is sensitive to metabolic state. Mesoderm migration also appears to be responsive to composition of the maternal diet, as we previously demonstrated that diet modulates the rate of NTDs in the FVB model19. In the NOD strain, NTD incidence is reduced by supplementation of folinic acid, as shown above, similar to the beneficial effects of folic acid in STZ-induced diabetic mouse pregnancies58. These findings support the conclusion that metabolic factors can affect mesoderm formation and migration, and -together with the results from our molecular analyses- identify novel cellular and molecular targets for the prevention of neural tube and other birth defects.

The most characteristic congenital malformations in human diabetic pregnancies are heart defects, neural tube defects, and caudal growth defects7,8,9,10, and have been postulated to arise before the 7th week of pregnancy7. Our results support the proposition that perturbed mesoderm migration during gastrulation is the common etiology for these seemingly heterogeneous birth defects59,60: (i) neural tube defects arise as a consequence of impaired mesoderm migration, as demonstrated here; (ii) early heart progenitors originate and migrate from the primitive streak61,62; and (iii) caudal growth defects are also consistent with altered mesoderm formation and migration63,64 in the posterior primitive streak. Similarly, mesodermal deficiencies are believed to underlie the vertebral, cardiac, renal and limb malformations of VACTERL65 and axial mesodermal dysplasia66 phenotypes, which have been linked to maternal diabetes67,68,69,70. Thus, our discovery of aberrant mesoderm migration during gastrulation in two different mouse models of Type I diabetes provides a unifying cellular mechanism that can explain both the developmental timing and the morphogenetic origin of the most common structural anomalies in diabetic embryopathy.

Methods Summary

All animal experiments were performed with prior approval of the Pennington Biomedical Research Center IACUC and in accordance with the “Guide for the care and use of laboratory animals” of the United States National Institutes of Health. Embryos were prepared at 8.5 days of gestation for histological or molecular analysis from hyperglycemic NOD or FVB dams, as well as from strain-matched normoglycemic control dams. Embryos with malformations were fixed, stained with DAPI, and imaged by 2-photon confocal microscopy. Optical sections were used to generate three-dimensional reconstructions of individual embryos using Imaris software. To determine etiology and identity of protrusion tissue, we performed gene expression profiling by expression tag sequencing on an AB SOLiD 5500XL sequencer; expression profiles were compared between protrusion tissue and open neural plate prepared by laser microdissection immediately anterior of neural tube closure site 1. Sequence reads were mapped (RefSeq RNA, mm9) using SOLiDSAGE to generate count data for each gene. Differential gene expression was determined using DESeq, with validation of select genes by qPCR. In situ hybridizations and immunohistochemical analyses were performed on cryosections following established protocols. Migratory capacity of cells in protrusions and posterior embryonic tissue was assessed in explant culture, using time-lapse video and phase contrast microscopy.

Additional Information

Accession codes: The SAGE results have been deposited in the Gene Expression Omnibus database under accession number GSE53075.

How to cite this article: Salbaum, J. M. et al. Novel Mode of Defective Neural Tube Closure in the Non-Obese Diabetic (NOD) Mouse Strain. Sci. Rep. 5, 16917; doi: 10.1038/srep16917 (2015).

Supplementary Material

Supplementary Movie S1
Download video file (2.3MB, mov)
Supplementary Information
srep16917-s2.pdf (143.4KB, pdf)

Acknowledgments

DNA sequencing was performed by the Pennington Biomedical Research Center Genomics Core Facility, and Confocal Microscopy, Real-time Imaging, and Laser Capture Microdissection were performed at the Cell Biology and Bioimaging Core Facility. Both core facilities are supported by the PBRC Nutrition and Obesity Research Center (NORC NIH-P30DK072476) and the PBRC Center of Biomedical Research Excellence (COBRE NIH-P20GM103528). The expert technical assistance from Richard Carmouche, Susan Newman and Diana Holmes is gratefully acknowledged. This project was funded through NIH grants R01-HD085017 and R01-HD055528 including Supplement HD055528-03S1 (to JMS), and R01-HD37804 including Supplement HD37804-S2 (to CK).

Footnotes

Author Contributions J.M.S. and J.M. performed embryo dissections, J.M. conducted Laser Dissections, C.Kr. prepared RNA, produced the SAGE libraries, and performed RT-PCR and in situ hybridization and histological staining experiments, assisted by N.H.; D.B. performed the confocal imaging and reconstructions, J.M.S. conducted the SAGE analyses and explant cultures, which were quantified by C.K.; C.K. and J.M.S. designed experiments, coordinated the project, performed bioinformatics analyses, and wrote the manuscript.

References

  1. Wallingford J. B., Niswander L. A., Shaw G. M. & Finnell R. H. The continuing challenge of understanding, preventing, and treating neural tube defects. Science 339, 1222002, doi: 10.1126/science.1222002 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Copp A. J., Stanier P. & Greene N. D. Neural tube defects: recent advances, unsolved questions, and controversies. Lancet Neurol 12, 799–810, doi: 10.1016/S1474-4422(13)70110-8 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Harris M. J. & Juriloff D. M. An update to the list of mouse mutants with neural tube closure defects and advances toward a complete genetic perspective of neural tube closure. Birth Defects Res A Clin Mol Teratol 88, 653–669, doi: 10.1002/bdra.20676 (2010). [DOI] [PubMed] [Google Scholar]
  4. Salbaum J. M. & Kappen C. Neural tube defect genes and maternal diabetes during pregnancy. Birth Defects Res A Clin Mol Teratol 88, 601–611, doi: 10.1002/bdra.20680 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Pangilinan F. et al. Evaluation of common genetic variants in 82 candidate genes as risk factors for neural tube defects. BMC Med Genet 13, 62, doi: 10.1186/1471-2350-13-62 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Smithells R. W., Sheppard S. & Schorah C. J. Vitamin dificiencies and neural tube defects. Arch Dis Child 51, 944–950 (1976). [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Mills J. L., Baker L. & Goldman A. S. Malformations in infants of diabetic mothers occur before the seventh gestational week. Implications for treatment. Diabetes 28, 292–293 (1979). [DOI] [PubMed] [Google Scholar]
  8. Kucera J. Rate and type of congenital anomalies among offspring of diabetic women. J Reprod Med 7, 73–82 (1971). [PubMed] [Google Scholar]
  9. Martinez-Frias M. L. Epidemiological analysis of outcomes of pregnancy in diabetic mothers: identification of the most characteristic and most frequent congenital anomalies. Am J Med Genet 51, 108–113, doi: 10.1002/ajmg.1320510206 (1994). [DOI] [PubMed] [Google Scholar]
  10. Goto M. P. & Goldman A. S. Diabetic embryopathy. Curr Opin Pediatr 6, 486–491 (1994). [DOI] [PubMed] [Google Scholar]
  11. Williams L. J. et al. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 66, 33–39, doi: 10.1002/tera.10060 (2002). [DOI] [PubMed] [Google Scholar]
  12. Kondo A., Kamihira O. & Ozawa H. Neural tube defects: prevalence, etiology and prevention. Int J Urol 16, 49–57, doi: 10.1111/j.1442-2042.2008.02163.x (2009). [DOI] [PubMed] [Google Scholar]
  13. Leiter E. H. The genetics of diabetes susceptibility in mice. Faseb J 3, 2231–2241 (1989). [DOI] [PubMed] [Google Scholar]
  14. Leiter E. H. Nonobese diabetic mice and the genetics of diabetes susceptibility. Curr Diab Rep 5, 141–148 (2005). [DOI] [PubMed] [Google Scholar]
  15. Otani H., Tanaka O., Tatewaki R., Naora H. & Yoneyama T. Diabetic environment and genetic predisposition as causes of congenital malformations in NOD mouse embryos. Diabetes 40, 1245–1250 (1991). [DOI] [PubMed] [Google Scholar]
  16. Morishima M., Ando M. & Takao A. Visceroatrial heterotaxy syndrome in the NOD mouse with special reference to atrial situs. Teratology 44, 91–100, doi: 10.1002/tera.1420440113 (1991). [DOI] [PubMed] [Google Scholar]
  17. Morishima M., Yasui H., Ando M., Nakazawa M. & Takao A. Influence of genetic and maternal diabetes in the pathogenesis of visceroatrial heterotaxy in mice. Teratology 54, 183–190, doi: (1996). [DOI] [PubMed] [Google Scholar]
  18. Pavlinkova G., Salbaum J. M. & Kappen C. Maternal diabetes alters transcriptional programs in the developing embryo. BMC Genomics 10, 274, doi: 10.1186/1471-2164-10-274 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kappen C., Kruger C., MacGowan J. & Salbaum J. M. Maternal diet modulates the risk for neural tube defects in a mouse model of diabetic pregnancy. Reprod Toxicol 31, 41–49, doi: 10.1016/j.reprotox.2010.09.002 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Beck S. et al. Extraembryonic proteases regulate Nodal signalling during gastrulation. Nat Cell Biol 4, 981–985, doi: 10.1038/ncb890 (2002). [DOI] [PubMed] [Google Scholar]
  21. Ramkumar N. & Anderson K. V. SnapShot: mouse primitive streak. Cell 146, 488–488 e482, doi: 10.1016/j.cell.2011.07.028 (2011). [DOI] [PubMed] [Google Scholar]
  22. Nishiyama A. et al. Uncovering early response of gene regulatory networks in ESCs by systematic induction of transcription factors. Cell Stem Cell 5, 420–433, doi: 10.1016/j.stem.2009.07.012 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Nelson A. C. et al. An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma. J Pathol 228, 274–285, doi: 10.1002/path.4082 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Takemoto T. et al. Tbx6-dependent Sox2 regulation determines neural or mesodermal fate in axial stem cells. Nature 470, 394–398, doi: 10.1038/nature09729 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Wilkinson D. G., Bhatt S. & Herrmann B. G. Expression pattern of the mouse T gene and its role in mesoderm formation. Nature 343, 657–659, doi: 10.1038/343657a0 (1990). [DOI] [PubMed] [Google Scholar]
  26. Chapman D. L., Agulnik I., Hancock S., Silver L. M. & Papaioannou V. E. Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation. Dev Biol 180, 534–542, doi: 10.1006/dbio.1996.0326 (1996). [DOI] [PubMed] [Google Scholar]
  27. Wardle F. C. & Papaioannou V. E. Teasing out T-box targets in early mesoderm. Curr Opin Genet Dev 18, 418–425, doi: 10.1016/j.gde.2008.07.017 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Copp A. J. et al. Regional differences in the expression of laminin isoforms during mouse neural tube development. Matrix Biol 30, 301–309, doi: 10.1016/j.matbio.2011.04.001 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Salmivirta K. et al. Binding of mouse nidogen-2 to basement membrane components and cells and its expression in embryonic and adult tissues suggest complementary functions of the two nidogens. Exp Cell Res 279, 188–201 (2002). [DOI] [PubMed] [Google Scholar]
  30. Rebustini I. T. et al. Laminin alpha5 is necessary for submandibular gland epithelial morphogenesis and influences FGFR expression through beta1 integrin signaling. Dev Biol 308, 15–29, doi: 10.1016/j.ydbio.2007.04.031 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Cagliero E., Forsberg H., Sala R., Lorenzi M. & Eriksson U. J. Maternal diabetes induces increased expression of extracellular matrix components in rat embryos. Diabetes 42, 975–980 (1993). [DOI] [PubMed] [Google Scholar]
  32. Burdsal C. A., Damsky C. H. & Pedersen R. A. The role of E-cadherin and integrins in mesoderm differentiation and migration at the mammalian primitive streak. Development 118, 829–844 (1993). [DOI] [PubMed] [Google Scholar]
  33. Jin J. Z. & Ding J. Cripto is required for mesoderm and endoderm cell allocation during mouse gastrulation. Dev Biol 381, 170–178, doi: 10.1016/j.ydbio.2013.05.029 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Arnold S. J., Hofmann U. K., Bikoff E. K. & Robertson E. J. Pivotal roles for eomesodermin during axis formation, epithelium-to-mesenchyme transition and endoderm specification in the mouse. Development 135, 501–511, doi: 10.1242/dev.014357 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Sun X., Meyers E. N., Lewandoski M. & Martin G. R. Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo. Genes Dev 13, 1834–1846 (1999). [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Guo Q. & Li J. Y. Distinct functions of the major Fgf8 spliceform, Fgf8b, before and during mouse gastrulation. Development 134, 2251–2260, doi: 10.1242/dev.004929 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Deng C. X. et al. Murine FGFR-1 is required for early postimplantation growth and axial organization. Genes Dev 8, 3045–3057 (1994). [DOI] [PubMed] [Google Scholar]
  38. Ciruna B. G., Schwartz L., Harpal K., Yamaguchi T. P. & Rossant J. Chimeric analysis of fibroblast growth factor receptor-1 (Fgfr1) function: a role for FGFR1 in morphogenetic movement through the primitive streak. Development 124, 2829–2841 (1997). [DOI] [PubMed] [Google Scholar]
  39. Kelly O. G., Pinson K. I. & Skarnes W. C. The Wnt co-receptors Lrp5 and Lrp6 are essential for gastrulation in mice. Development 131, 2803–2815, doi: 10.1242/dev.01137 (2004). [DOI] [PubMed] [Google Scholar]
  40. Xue Y. et al. Mesodermal patterning defect in mice lacking the Ste20 NCK interacting kinase (NIK). Development 128, 1559–1572 (2001). [DOI] [PubMed] [Google Scholar]
  41. Kitajima S., Takagi A., Inoue T. & Saga Y. MesP1 and MesP2 are essential for the development of cardiac mesoderm. Development 127, 3215–3226 (2000). [DOI] [PubMed] [Google Scholar]
  42. Hart A. H. et al. Mixl1 is required for axial mesendoderm morphogenesis and patterning in the murine embryo. Development 129, 3597–3608 (2002). [DOI] [PubMed] [Google Scholar]
  43. Bloomekatz J., Grego-Bessa J., Migeotte I. & Anderson K. V. Pten regulates collective cell migration during specification of the anterior-posterior axis of the mouse embryo. Dev Biol 364, 192–201, doi: 10.1016/j.ydbio.2012.02.005 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Migeotte I., Omelchenko T., Hall A. & Anderson K. V. Rac1-dependent collective cell migration is required for specification of the anterior-posterior body axis of the mouse. PLoS Biol 8, e1000442, doi: 10.1371/journal.pbio.1000442 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Migeotte I., Grego-Bessa J. & Anderson K. V. Rac1 mediates morphogenetic responses to intercellular signals in the gastrulating mouse embryo. Development 138, 3011–3020, doi: 10.1242/dev.059766 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Saxton T. M. & Pawson T. Morphogenetic movements at gastrulation require the SH2 tyrosine phosphatase Shp2. Proc Natl Acad Sci USA 96, 3790–3795 (1999). [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Wilson V., Manson L., Skarnes W. C. & Beddington R. S. The T gene is necessary for normal mesodermal morphogenetic cell movements during gastrulation. Development 121, 877–886 (1995). [DOI] [PubMed] [Google Scholar]
  48. Monkley S. J. et al. Disruption of the talin gene arrests mouse development at the gastrulation stage. Dev Dyn 219, 560–574, doi: (2000). [DOI] [PubMed] [Google Scholar]
  49. Merrill B. J. et al. Tcf3: a transcriptional regulator of axis induction in the early embryo. Development 131, 263–274, doi: 10.1242/dev.00935 (2004). [DOI] [PubMed] [Google Scholar]
  50. Qian L., Mahaffey J. P., Alcorn H. L. & Anderson K. V. Tissue-specific roles of Axin2 in the inhibition and activation of Wnt signaling in the mouse embryo. Proc Natl Acad Sci USA 108, 8692–8697, doi: 10.1073/pnas.1100328108 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Rakeman A. S. & Anderson K. V. Axis specification and morphogenesis in the mouse embryo require Nap1, a regulator of WAVE-mediated actin branching. Development 133, 3075–3083, doi: 10.1242/dev.02473 (2006). [DOI] [PubMed] [Google Scholar]
  52. Zohn I. E. et al. p38 and a p38-interacting protein are critical for downregulation of E-cadherin during mouse gastrulation. Cell 125, 957–969, doi: 10.1016/j.cell.2006.03.048 (2006). [DOI] [PubMed] [Google Scholar]
  53. Garcia-Garcia M. J. & Anderson K. V. Essential role of glycosaminoglycans in Fgf signaling during mouse gastrulation. Cell 114, 727–737 (2003). [DOI] [PubMed] [Google Scholar]
  54. Herion N. J., Salbaum J. M. & Kappen C. Traffic jam in the primitive streak: The role of defective mesoderm migration in birth defects. Birth Defects Res A Clin Mol Teratol 100, 608–622, doi: 10.1002/bdra.23283 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Ando S., Otani H., Tanaka O. & Moritake K. Morphological Analysis of Neural Tube Defects in Non-obese Diabetic (NOD) Mouse Embryos. Cong. Anom. 31, 23–32 (1991). [Google Scholar]
  56. Copp A. J., Greene N. D. & Murdoch J. N. The genetic basis of mammalian neurulation. Nat Rev Genet 4, 784–793, doi: 10.1038/nrg1181 (2003). [DOI] [PubMed] [Google Scholar]
  57. Shum A. S. & Copp A. J. Regional differences in morphogenesis of the neuroepithelium suggest multiple mechanisms of spinal neurulation in the mouse. Anat Embryol (Berl) 194, 65–73 (1996). [DOI] [PubMed] [Google Scholar]
  58. Oyama K. et al. Folic acid prevents congenital malformations in the offspring of diabetic mice. Endocr J 56, 29–37 (2009). [DOI] [PubMed] [Google Scholar]
  59. Khoury M. J., Cordero J. F., Greenberg F., James L. M. & Erickson J. D. A population study of the VACTERL association: evidence for its etiologic heterogeneity. Pediatrics 71, 815–820 (1983). [PubMed] [Google Scholar]
  60. Martinez-Frias M. L., Frias J. L. & Opitz J. M. Errors of morphogenesis and developmental field theory. Am J Med Genet 76, 291–296 (1998). [PubMed] [Google Scholar]
  61. Garcia-Martinez V. & Schoenwolf G. C. Primitive-streak origin of the cardiovascular system in avian embryos. Dev Biol 159, 706–719, doi: 10.1006/dbio.1993.1276 (1993). [DOI] [PubMed] [Google Scholar]
  62. Yutzey K. E. & Kirby M. L. Wherefore heart thou? Embryonic origins of cardiogenic mesoderm. Dev Dyn 223, 307–320, doi: 10.1002/dvdy.10068 (2002). [DOI] [PubMed] [Google Scholar]
  63. Bohring A. et al. Polytopic anomalies with agenesis of the lower vertebral column. Am J Med Genet 87, 99–114 (1999). [PubMed] [Google Scholar]
  64. Rougemont A. L. et al. Caudal dysgenesis, sirenomelia, and situs inversus totalis: a primitive defect in blastogenesis. Am J Med Genet A 146A, 1470–1476, doi: 10.1002/ajmg.a.32081 (2008). [DOI] [PubMed] [Google Scholar]
  65. Solomon B. D. VACTERL/VATER Association. Orphanet J Rare Dis 6, 56, doi: 10.1186/1750-1172-6-56 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Russell L. J., Weaver D. D. & Bull M. J. The axial mesodermal dysplasia spectrum. Pediatrics 67, 176–182 (1981). [PubMed] [Google Scholar]
  67. Loffredo C. A., Wilson P. D. & Ferencz C. Maternal diabetes: an independent risk factor for major cardiovascular malformations with increased mortality of affected infants. Teratology 64, 98–106, doi: 10.1002/tera.1051 (2001). [DOI] [PubMed] [Google Scholar]
  68. Stevenson R. E. & Hunter A. G. Considering the Embryopathogenesis of VACTERL Association. Mol Syndromol 4, 7–15, doi: 10.1159/000346192 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Depraetere M., Dehauwere R., Marien P. & Fryns J. P. Severe axial mesodermal dysplasia spectrum in an infant of a diabetic mother. Genet Couns 6, 303–307 (1995). [PubMed] [Google Scholar]
  70. Dinleyici E. C. et al. Severe fatal course of axial mesodermal dysplasia spectrum associated with complex cardiac defect in an infant of a mother with insulin dependent diabetes. Am J Med Genet A 143A, 2156–2159, doi: 10.1002/ajmg.a.31895 (2007). [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Movie S1
Download video file (2.3MB, mov)
Supplementary Information
srep16917-s2.pdf (143.4KB, pdf)

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES